Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 2022
DOI: 10.1007/978-981-16-4392-7_22
|View full text |Cite
|
Sign up to set email alerts
|

Drug Delivery Systems for Respiratory Infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…In case of nasopharyngeal and lung infection cases, a drug which can be delivered through inhalation is preferred compared to oral or intra venous drugs [5]. A drug which can be delivered through inhalation can give better results with low drug doses in respiratory infections and therefore impart low adverse effects in non-targeted tissues [6,7]. Staphyloxanthin (an orange carotenoid pigment) of S. aureus provides three-way protection against: antibiotics (by enhancing membrane integrity), host neutrophilbased attack and oxidative damage to the bacterial cells [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…In case of nasopharyngeal and lung infection cases, a drug which can be delivered through inhalation is preferred compared to oral or intra venous drugs [5]. A drug which can be delivered through inhalation can give better results with low drug doses in respiratory infections and therefore impart low adverse effects in non-targeted tissues [6,7]. Staphyloxanthin (an orange carotenoid pigment) of S. aureus provides three-way protection against: antibiotics (by enhancing membrane integrity), host neutrophilbased attack and oxidative damage to the bacterial cells [8,9].…”
Section: Introductionmentioning
confidence: 99%